Funding & Investments Related News

Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M

Ben Belldegrun of Pontifax AgTech Joins Inocucor’s Board of Directors DENVER, April 19, 2018 — Inocucor Corporation, a developer and producer of biological crop inputs for high-value produce and row crops, announced the final close of its Series B funding round [...]

Indee Labs secures funding to develop unique gene therapy manufacturing technology in Australia

Biomedtech Horizons Project Will See Cancer-Curing Gene Therapies Manufactured For The Masses 6:30pm AEST, Tuesday 17 April, Melbourne, Australia – MTPConnect and the Minister for Health, the Hon Greg Hunt MP, today announced that Indee Labs will receive grant funding of nearly A$1M [...]

Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS

Major investment by Coalition for Epidemic Preparedness Innovations (CEPI) to advance vaccine development and manufacturing on two of CEPI’s highest priority infectious diseases PLYMOUTH MEETING, Pa. and OSLO, Norway, April 11, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and CEPI – the [...]

Ecovia Renewables Announces Major Partnership; Raises $1 Million In Seed Financing

ANN ARBOR, MICHIGAN, April 6th, 2018— Ecovia Renewables Inc. announced today that the company has signed a multi-year joint-development agreement with Seppic Inc, a member of the Seppic Group, a leading designer and manufacturer of specialty ingredients. Under the agreement, [...]

Poseida Raises $30.5 Million in Series B Financing

SAN DIEGO – April 3, 2018 – Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced the company has raised $30.5 million in an oversubscribed Series B financing round, led by Longitude Capital. [...]

Codexis Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of $9.25 per share. Net proceeds to Codexis from the [...]

tadalafiltablets findviagra.com http://xanaxonlinebuy.com/